Regeneron Pharmaceuticals
REGN
REGN
1,325 hedge funds and large institutions have $98.8B invested in Regeneron Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 124 funds opening new positions, 542 increasing their positions, 427 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 1,303 → 1,325 (+22)
0.6% more ownership
Funds ownership: 86.18% → 86.78% (+0.6%)
30% less call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.55B
Holders
1,325
Holding in Top 10
29
Calls
$1.09B
Puts
$1.55B
Top Buyers
| 1 | +$578M | |
| 2 | +$323M | |
| 3 | +$240M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$173M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$171M |
Top Sellers
| 1 | -$152M | |
| 2 | -$149M | |
| 3 | -$129M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$116M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$93.8M |